Big Pharma, with eye on Anthropic, says AI is shrinking drug discovery timelines
Reuters

Big Pharma, with eye on Anthropic, says AI is shrinking drug discovery timelines

By Michael Erman, Bhanvi Satija and Patrick Wingrove NEW YORK/LONDON, Nov 20 (Reuters) - Artificial intelligence has sped up early-stage drug development work at some of the world's largest pharmaceutical companies this year, cutting by as much as half the time it takes to produce new molecules and
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.